Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 30, 2017 12:55 pm UTC| Business
NORTHVALE, N.J., May 30, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an...
Hamilton Lane Announces Addition of Two New Independent Directors to Board
May 30, 2017 12:55 pm UTC| Business
BALA CYNWYD, Pa., May 30, 2017 -- Hamilton Lane (NASDAQ:HLNE) announced the addition of Leslie F. Varon and David Berkman as independent directors to its Board, effective May 26, 2017. Ms. Varon was also appointed Chair...
Viksit Bharat 2026: Fiscal Muscle, Factory Revival, and the War on Speculation